Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies
External Expert Profile
Shelley Farrar
Latest Publications
2021 OHE Annual Report to the Charity Commission
Read more
© Lina Trochez/Unsplash
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
The Lower Drug Costs Now Act and Pharmaceutical Innovation
Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective
Ethical and Economic Issues in the Appraisal of Medicines for Ultra-Rare Conditions
